Clinical Trial Update: Study of Psilocybin for Anorexia in Young Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating psilocybin for anorexia nervosa in young adults. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Marissa Raymond-Flesch, MD, MPH | Conditions: Anorexia Nervosa | Phase 2 | Status: RECRUITING